Characterization and validation of a preventative therapy for hypertrophic cardiomyopathy in a murine model of the disease

Medicine and Dentistry

• Biological Marker 16%
• Cardiac Muscle Cell 33%
• Cardiac Troponin 83%
• Diseases 100%
• Echocardiography 16%
• Flavoprotein 33%
• Gene Mutation 16%
• Hypertrophic Cardiomyopathy 100%
• L-Type Calcium Channel 16%
• Metabolomics 16%
• Mitochondrial Membrane Potential 33%
• Myocardial Disease 50%
• Targeted Therapy 16%
• Troponin I 83%
• Ventricular Hypertrophy 16%

Biochemistry, Genetics and Molecular Biology

• Anaplerosis 20%
• Cardiac Muscle Cell 40%
• Cardiac Troponin 100%
• Flavoprotein 40%
• Gene Mutation 20%
• L-Type Calcium Channel 20%
• Metabolic Pathway 20%
• Metabolomics 20%
• Mitochondrial Membrane Potential 40%
• Troponin I 100%